Announcements Trials
Browse Landscape

Phase

Phase 2/3 3Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 10OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Exercise 16Standard of Care 10Control Groups 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 6Radiotherapy 6Endoscopic Mucosal Resection 6Drug Therapy 6Blood Specimen Collection 6Indocyanine Green 5apatinib 4anlotinib 4Metformin 4Magnetic Resonance Spectroscopy 4Laparoscopy 4Fluorouracil 4Cisplatin 4camrelizumab 3Vitamin D 3Ultrasonography 3Therapeutics 3Sentinel Lymph Node Biopsy 3Saline Solution 3Radiofrequency Ablation 3Quality of Life 3Proton Therapy 3Preoperative Exercise 3Methylene Blue 3Mammography 3Magnetic Resonance Imaging 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × Zoledronic Acid × Clear all
NCT00489905 2013-10-23

Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Hospital Authority, Hong Kong

Phase NA Completed
24 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡